Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Shukra Pharmaceuticals Ltd. (SHUKRAPHAR)
Market Closed
15 Oct, 10:00 PM
MSE
All
(1)
IN
(1)
MSE
Primary
₹
66.
76
-0.24
-0.3582%
₹
14.48B
Market Cap
262.38
P/E Ratio
0.04%
Div Yield
151,046
Volume
0
Eps
₹
67
Previous Close
Watching
Watch
Add Transaction
Day Range
66.57
67.36
Year Range
26.3
75.5
Want to track
SHUKRAPHAR
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Shukra Pharmaceuticals Ltd. (SHUKRAPHAR) Statistics
Valuation metrics
Market Cap
14.48B
Enterprise value
29.33B
Trailing P/E (ttm)
87
Forward P/E
-
PEG ratio
-4.06
Price/Sales (ttm)
39.19
Price/Book (mrq)
32.78
Enterprise Value/Revenue
39.19
Enterprise Value/EBITDA
58.62
Overview
Shares outstanding
437.88M
Float
46.25M
Shares short
-
% Held by insiders
0.89%
% Held by institutions
-
Average volume (10 days)
1.3M
Average volume (90 days)
628.45K
Price summary
52-Week low
26.3
52-Week high
75.5
Beta
0.65
50-Day moving average
54.94
200-Day moving average
38.03
Dividends and splits
Forward annual dividend rate
0.04
Forward annual dividend yield
0.0013%
Trailing annual dividend rate
0.02
Trailing annual dividend yield
0.0003%
5-Year annual dividend yield
-
Payout ratio
0.2
Dividend Date
21 Sep 2026
Ex-Dividend Date
21 Sep 2026
Last split factor
10:1
Last split Date
21 Mar 2025
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.45%
Operating margin
0.57%
Operational effectiveness
Return on assets
0.29%
Return on equity
0.44%
Income Statement
Revenue (ttm)
645.69M
Revenue per share (ttm)
1.7
Quarterly revenue growth (yoy)
2.45%
Gross profit (ttm)
527.17M
EBITDA
403.84M
Net income to common (ttm)
291.61M
Diluted EPS (ttm)
0.77
Quarterly earnings growth (yoy)
5.44%
Balance Sheet
Total cash (mrq)
133.58M
Total cash per share (mrq)
0.14
Total debt (mrq)
37.56M
Total Debt/Equity (mrq)
0.02
Current ratio (mrq)
3.6%
Book value per share (mrq)
2.04
Cash Flow
Cash flow statement
66.8M
Levered free cash flow (LFCF)
95.75M